(Q42659869)
Statements
Efficacy and safety of risperidone in the treatment of schizoaffective disorder: initial results from a large, multicenter surveillance study. Group for the Study of Risperidone in Affective Disorders (GSRAD) (English)
Vieta E
1 reference
E Vieta
M Herraiz
A Fernández
C Gastó
A Benabarre
F Colom
A Martínez-Arán